T cells protect our bodies against attackers like bacteria, cancer, and the AIDS virus. Scientists at Stanford have found a way to not only target them to threats more effectively (past work), but to allow them to act independent of other immune cells (new work). (Source: Laplacian Files)
Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems
Forgive the Wikipedia link, Ribozyme.
Great articles. Thanks for the ping.
Thank you Ernest. I’ve been an investor in Dendreon for over 7 years. Today was the culmination of 15 years of research, trials and yes, unnecessary patient deaths caused by an FDA delay the first time it came up for approval. Today is the begining of a new way to treat cancer. Prosate cancer is only the first. Dendreon has a pipeline; this is no one-trick pony. And yes, i’d recommend buying some stock. This will be Amgn or Celgene within a few years.